SHORT MINI FUTURE WARRANT - MERCK & CO. | Market Closed - BOERSE MUENCHEN 14:25:42 2024-05-10 EDT | ||
| 6.03 EUR | -0.50% |
|
| Current month | -2.90% | ||
| 1 month | -5.63% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
MERCK & CO., INC.
Latest news about MERCK & CO., INC.
More news
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-05-10 | 6.03 | -0.50% | 0 |
| 24-05-09 | 6.06 | -1.14% | 0 |
| 24-05-08 | 6.13 | -0.33% | 0 |
| 24-05-07 | 6.15 | -2.38% | 0 |
| 24-05-06 | 6.3 | +0.48% | 0 |
Real-time BOERSE MUENCHEN
Last update May 10, 2024 at 02:25 pm
More quotesStatic data
| Product type | Knock-Out mit Stop Loss |
|---|---|
| Buy / Sell | PUT |
| Underlying | MERCK & CO., INC. |
| Issuer | Goldman Sachs |
| WKN | GZ4A8S |
| ISIN | DE000GZ4A8S9 |
| Date issued | 2022-11-25 |
| Strike | 195.4 $ |
| Maturity | Unlimited |
| Parity | 10 : 1 |
| Emission price | 8.59 € |
| Emission volume | N/A |
| Settlement | Barausgleich |
| Currency | EUR |
Technical Indicators
| Highest since issue | 9.13 € |
|---|---|
| Lowest since issue | 5.79 € |
Company Profile
Merck & Co., Inc. specializes in the development, production, and marketing of therapeutic products and vaccines sold under prescription. Net sales break down by activity as follows:
- sale of pharmaceutical products (69.7%): for treating hypertension, osteoporosis, atherosclerosis, respiratory, bacterial and fungal, ophthalmologic, and urological diseases, acute migraine, hair loss in men, etc.;
- sale of vaccines (18%);
- sale of animal health products (9.4%);
- other (2.9%).
Net sales are distributed geographically as follows: the United States (45.9%), Europe/Middle East/Africa (24.5%), China (8.8%), Japan (6.1%), Asia/Pacific (6.1%), Latin America (4.3%) and other (4.3%).
Sector
-
Consensus: Merck & Co., Inc.
Sell
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
130.1
USD
Average target price
141.6
USD
Spread / Average Target
+8.90%
- Stock Market
- Certificates
- Certificat